Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx.
about
Lessons from rare tumors: hepatic lymphoepithelioma-like carcinomasGenetics of neoplasia--impact of ecogenetics on oncogenesis. A review.EBV gene expression in an NPC-related tumour.Epstein-Barr virus involvement in T-cell malignancy: significance in adult T-cell leukemia.Purified hexameric Epstein-Barr virus-encoded BARF1 protein for measuring anti-BARF1 antibody responses in nasopharyngeal carcinoma patients.A synthetic peptide defines a serologic IgA response to a human papillomavirus-encoded nuclear antigen expressed in virus-carrying cervical neoplasia.EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus.Human papillomavirus 16 detected in nasopharyngeal carcinomas in white Americans but not in endemic Southern Chinese patientsAntibodies against synthetic peptides react with the second Epstein-Barr virus-associated nuclear antigen.Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinomaThe Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases.Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient.Epidemiologic aspects of Epstein-Barr virus (EBV)-associated diseases.Epstein-Barr virus-containing epithelial cells from nasopharyngeal carcinoma produce interleukin 1 alphaEpstein-barr virus-associated smooth muscle tumor of the larynx: report of a rare case mimicking leiomyosarcoma.Antibodies to Epstein-Barr virus in patients with nasopharyngeal carcinoma and in comparison groups.Graft-vs-tumor effect in patients with advanced nasopharyngeal cancer treated with nonmyeloablative allogeneic PBSC transplantation.Enhanced oncogenic behavior of human and mouse cells after cellular hybridization with Burkitt tumor cellsEpstein-Barr virus: the path from association to causality for a ubiquitous human pathogen.Direct sequencing and characterization of a clinical isolate of Epstein-Barr virus from nasopharyngeal carcinoma tissue by using next-generation sequencing technologyNonmyeloablative allogeneic stem cell transplantation for nasopharyngeal carcinomaThe mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cellsUndifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia.Presence of the diffuse early antigen of Epstein-Barr virus in lymphomas and lymphoproliferative disorders.Epstein-Barr virus and carcinomas: rare association of the virus with gastric adenocarcinomas.Cytogenetics of malignant epithelial cells and lymphoblastoid cell lines from nasopharyngeal carcinoma.C-type virus particles in human urogenital tumours after heterotransplantation into nude miceIn vitro immune responses to PPD, extracts from Raji cells and nasopharyngeal carcinoma biopsies in NPC leucocytesFrequency and levels of antibodies to Epstein-Barr virus-specific DNase are elevated in patients with nasopharyngeal carcinoma.Epstein-Barr virus glycoprotein homologous to herpes simplex virus gB.Epstein-Barr virus transcription in nasopharyngeal carcinoma.Detection of Epstein-Barr virus and human papillomavirus in head and neck tumors.Detection of Epstein-Barr virus DNA sequences in nasopharyngeal carcinoma cells by enzymatic DNA amplification.Epstein-Barr virus nuclear antigen 1 linear epitopes that are reactive with immunoglobulin A (IgA) or IgG in sera from nasopharyngeal carcinoma patients or from healthy donors.One of two Epstein-Barr virus nuclear antigens contains a glycine-alanine copolymer domain.Antibodies against a synthetic peptide identify the Epstein-Barr virus-determined nuclear antigen.Regulation of angiogenesis in malignancies associated with Epstein-Barr virus and Kaposi's sarcoma-associated herpes virus.Expression of a second Epstein-Barr virus-determined nuclear antigen in mouse cells after gene transfer with a cloned fragment of the viral genomeMy journey to DNA repair.BamHI-A rightward frame 1, an Epstein-Barr virus-encoded oncogene and immune modulator.
P2860
Q28087354-CEDC800C-B741-4D48-B088-43D9B1993082Q30500345-5F47A2E1-2AAB-4889-A6E0-9D4F990D8E29Q33576708-2ACCC6C4-CF8E-46FC-A4B2-47CB3E2A79F7Q33643988-AB4470A2-48C9-4360-A98B-BBA81B78F78CQ33760249-ED83F5BA-570B-4D93-859C-DFA5EB818D9AQ33859093-FEB34D18-195B-4800-B2E9-FBA1DEE6F343Q33860748-C7A71D0C-D824-4F7D-9CC1-EA288DBF8BCFQ33901342-405341FF-7B4D-4BA7-BB52-443F19CE04EAQ33931549-D8ACBEB8-E7A3-46F7-AAF1-CEB0AE59E02EQ34089491-D4788C98-823E-424A-9CCE-1F7127297727Q34099074-AA638DB8-A7F2-4BB7-8BBD-EC9E4EB2E532Q34228526-67D4EE74-34D9-4468-AB99-6F83C8FE9C19Q34252368-9F333CFF-0F7A-40BC-A4BD-350CD3B773DCQ34343731-B8476367-48AD-40BE-8136-90C216B0BB08Q34376346-6530C1E7-6B7F-4DE5-AF54-0C58C57148E8Q34706994-A6EC9607-A953-4792-80A7-577FC782C1A3Q34771143-03380DEE-4EC2-4C7B-9ED5-52543E64091CQ35065184-C473A165-5373-4127-8551-EECAC53855BAQ35236719-764F2919-98E9-4A36-A436-0C5674E7951EQ35363383-DB657443-397A-4703-A0C2-A58F60512ED8Q35583804-BDFA5A29-085D-4037-8C5B-2673F5D66599Q35764478-B90A0B46-953F-4BE8-95CF-A1D96D4E64A6Q35798133-9AA248BB-9537-40F3-BA93-228EA7E9D388Q35831688-7A731135-FD59-4F75-9283-1D3AD0C5D673Q35977813-EAE88E39-E00F-4E9F-BF66-3E86A0564AE8Q36042086-19186344-9CD2-4748-B2D0-8D9878C523E1Q36042691-41F92759-A17B-40F6-97B5-91E17A320650Q36069431-A12BC8D8-5EF1-4050-AB4F-7BD203E7A35BQ36412130-718DADC4-AEA6-4FC6-83F8-1D0C5A448805Q36884762-90E06767-59F0-4965-9474-0FE1A10077A7Q36909993-3C939F92-8327-4468-A410-0AABCBBBE702Q37060675-2C92CF6F-54BF-4EC3-92D7-A639A7269C8EQ37191858-F44C3B53-42D0-497F-BB4D-6156AEB68D83Q37243613-8D67765E-80AB-422A-8241-C46ABCC4ADD7Q37349287-CCDDA030-95B0-4140-B935-77FA42248BC7Q37560230-B93A27CC-D8CD-45AF-8078-EBA4DF426A5AQ37590325-2FEEC528-3DE0-45A2-9A73-250652AF5797Q37688813-E3F63F3E-DB97-4E4A-BE8B-3872DE0746B8Q38085813-391D0309-F520-4889-8D95-D82F34917F38Q38133428-3E9391FA-9F4D-4FBF-B514-C84FFAC09740
P2860
Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx.
description
1974 nî lūn-bûn
@nan
1974 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1974 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1974年の論文
@ja
1974年論文
@yue
1974年論文
@zh-hant
1974年論文
@zh-hk
1974年論文
@zh-mo
1974年論文
@zh-tw
1974年论文
@wuu
name
Direct evidence for the presen ...... carcinoma of the nasopharynx.
@ast
Direct evidence for the presen ...... carcinoma of the nasopharynx.
@en
type
label
Direct evidence for the presen ...... carcinoma of the nasopharynx.
@ast
Direct evidence for the presen ...... carcinoma of the nasopharynx.
@en
prefLabel
Direct evidence for the presen ...... carcinoma of the nasopharynx.
@ast
Direct evidence for the presen ...... carcinoma of the nasopharynx.
@en
P2093
P2860
P356
P1476
Direct evidence for the presen ...... carcinoma of the nasopharynx.
@en
P2093
P2860
P304
P356
10.1073/PNAS.71.12.4737
P407
P577
1974-12-01T00:00:00Z